DRTS
Alpha Tau Medical Ltd.
NASDAQ · ILHealthcareBiotechnology
$13.47-0.59%
Price as of Jul 20, 2026
DRTS valuation
Alpha Tau Medical Ltd. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 167.11x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 17.09x
- Price / sales
- —
- Price / cash flow
- -44.43x
Enterprise value
- Enterprise value
- $1.1B
- EV / sales
- —
- EV / EBITDA
- -24.92x
- EV / EBIT
- -24.19x
- Market cap
- $1.2B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.